Skandinaviska Enskilda Banken (SEB)’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Sell
26,865
-26,865
-50% -$443K 0.02% 100
2026
Q1
$875K Buy
+53,730
New +$841K 0.02% 101
2021
Q4
Sell
-130,477
Closed -$2.54M 1060
2021
Q3
$2.54M Sell
130,477
-340,019
-72% -$6.75M 0.01% 586
2021
Q2
$10.7M Sell
470,496
-55,123
-10% -$1.14M 0.07% 269
2021
Q1
$9.66M Buy
525,619
+385,677
+276% +$6.32M 0.06% 270
2020
Q4
$2.09M Buy
+139,942
New +$1.83M 0.01% 639

Other funds holding SEM

Skandinaviska Enskilda Banken (SEB)'s SEM Position: Q2 2026 in Review

Skandinaviska Enskilda Banken (SEB) reduced its Select Medical (SEM) stake by 50% in Q2 2026, selling an estimated $443K and leaving 26,865 shares worth $444K. The position accounts for 0.02% of the portfolio, ranked #100.

Skandinaviska Enskilda Banken (SEB) first reported a position in SEM in Q4 2020 and has held it in 6 quarters since. The position peaked at $10.7M in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Skandinaviska Enskilda Banken (SEB) held 26,865 shares of Select Medical worth $444K as of Q2 2026.
  • Skandinaviska Enskilda Banken (SEB) sold 26,865 Select Medical shares in Q2 2026, an estimated $443K.
  • Select Medical made up 0.02% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q2 2026, its #100 holding.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Select Medical in Q4 2020 and has held it in 6 quarters since.
  • Skandinaviska Enskilda Banken (SEB)'s Select Medical position peaked at $10.7M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2026, filed 10 Aug 2026.